Showing results (1051-1060 of 1,370) with videos related to
Sort By:
Pageof 137
Heart Rhythm|February 25, 2017
Progression of paroxysmal to persistent atrial fibrillation: 10-year follow-up in the Canadian Registry of Atrial FibrillationGareth J Padfield, Christian Steinberg, Janice Swampillai, et al.Experimental Biology and Medicine (Maywood, N.J.)|September 2, 2025
Natural killer cell subpopulations in the peripheral blood of single ventricle/hypoplastic left heart syndrome patients via single-cell RNA sequencingHui-Qi Qu, Kushagra Goel, Kayleigh Ostberg, et al.The Lancet. Neurology|February 7, 2012
Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trialHans-Christoph Diener, John Eikelboom, Stuart J Connolly, et al.The Journal of Bone and Joint Surgery. American Volume|September 21, 2012
The association between preoperative spinal cord rotation and postoperative C5 nerve palsyMark S Eskander, Steve M Balsis, Chris Balinger, et al.Circulation. Cardiovascular Quality and Outcomes|March 25, 2024
Estimating Vitamin K Antagonist Anticoagulation Benefit in People With Atrial Fibrillation Accounting for Competing Risks: Evidence From 12 Randomized TrialsSachin J Shah, Carl van Walraven, Sun Young Jeon, et al.Chemical Biology & Drug Design|February 12, 2009
Identification of allosteric PIF-pocket ligands for PDK1 using NMR-based fragment screening and 1H-15N TROSY experimentsBrian J Stockman, Michael Kothe, Darcy Kohls, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|April 13, 2005
Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkeyDeeba Husain, Ivana Kim, Danny Gauthier, et al.Lancet (London, England)|April 6, 2022
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 studyJonathan P Piccini, Valeria Caso, Stuart J Connolly, et al.Surgery|September 16, 1999
A pilot study evaluating the efficacy of a fully acetylated poly-N-acetyl glucosamine membrane formulation as a topical hemostatic agentD J Cole, R J Connolly, M W Chan, et al.Journal of Cardiovascular Electrophysiology|July 1, 2009
Effect of metoprolol on quality of life in the Prevention of Syncope TrialRobert S Sheldon, Joseph E Amuah, Stuart J Connolly, et al.Pageof 137